Authors:
Raderer, M
Osterreicher, C
Machold, K
Formanek, M
Fiebiger, W
Penz, M
Dragosics, B
Chott, A
Citation: M. Raderer et al., Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease, ANN ONCOL, 12(7), 2001, pp. 937-939
Authors:
Scheithauer, W
Kornek, GV
Schuell, B
Ulrich-Pur, H
Penz, M
Raderer, M
Lang, F
Schneeweiss, B
Lenauer, A
Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714
Authors:
Penz, M
Kornek, GV
Raderer, M
Ulrich-Pur, H
Fiebiger, W
Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422
Authors:
Kornek, GV
Ulrich-Pur, H
Penz, M
Haider, K
Kwasny, W
Depisch, D
Kovats, E
Lang, F
Schneeweiss, B
Scheithauer, W
Citation: Gv. Kornek et al., Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor, J CL ONCOL, 19(3), 2001, pp. 621-627
Authors:
Scheithauer, W
Kornek, GV
Ulrich-Pur, H
Penz, M
Raderer, M
Salek, T
Haider, K
Kwasny, W
Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Authors:
Kwasny, W
Kornek, G
Haider, K
Valencak, J
Ulrich-Pur, H
Penz, M
Lang, F
Depisch, D
Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
Authors:
Raderer, M
Vorbeck, F
Formanek, M
Osterreicher, C
Valencak, J
Penz, M
Kornek, G
Hamilton, G
Dragosics, B
Chott, A
Citation: M. Raderer et al., Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma, BR J CANC, 83(4), 2000, pp. 454-457